First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
Sheng, Xinan, Bi, Feng, Ren, Xiubao, Cheng, Ying, Wang, Jinwan, Rosbrook, Brad, Jiang, Ming, Guo, JunLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0442
Date:
July, 2018
File:
PDF, 1.47 MB
english, 2018